---
title: Slide 3
image: accionesempresas_ENG.png
---

# Companies profit with the pandemic

Companies have increased their profits with the development of COVID-19 vaccines. [AstraZeneca](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000901832/000110465922025720/azn-20211231x20f.htm) reported a **19% increase in revenue in 2022**. In December 2022, [BioNtech](https://www.sec.gov/ix?doc=/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm) **shares hit a high record**, trading at USD 185.96. [Ugur Sahin](https://www.sec.gov/ix?doc=/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm), CEO and owner of 17.4% of the company, **got a double salary increase**. [2022 Pfizer's revenue totaled $100.33B](https://s28.q4cdn.com/781576035/files/doc_financials/2022/q4/Q4-2022-PFE-Earnings-Release.pdf), **up by 23.42% from 2021**. [CEO Albert Bourla](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000078003/000007800323000040/pfe-20230315.htm#i64b8bbaec1454cdb81dd0869649de7b6_133) was paid $33.01M, $8M more than the previous year, **the highest in Pfizer's history**. [Moderna, Inc.](https://www.sec.gov/ix?doc=/Archives/edgar/data/1682852/000168285222000012/mrna-20211231.htm) reported a revenue of $19.263 million in 2023. This was **a 4.29% increase from its earnings in 2021**. [Stephane Bancel](https://www.forbes.com/profile/stephane-bancel/?sh=5b0204743742), the CEO of Moderna, has increased his control over the company by acquiring 5.45% of its shares. He is now ranked 568th among the wealthiest people in the world, **with an estimated fortune of 4.7 billion dollars**.
